Cell-based therapies for renal ischemia-reperfusion injury: mesenchymal stem cells versus endothelial progenitor cells

Andreas Meyer, Anne Tischer, Stephan Huber, Peter Bartenstein, Karl-Walter Jauch, Marcus Hacker, Markus Guba, Joachim Andrassy & Tanja Herrler
Introduction: Cell-based therapies were reported to improve early kidney function in experimental models of renal ischemia-reperfusion injury. This study examines and compares the therapeutic effects of mesenchymal stem cells (MSC) and endothelial progenitor cells (EPC) as well as their regenerative[for full text, please go to the a.m. URL]